A Treatment of Herpes Zoster Using the Bi-Digital O-Ring Test


A Treatment of Herpes Zoster Using the Bi-Digital O-Ring Test


As a treatment of Herpes Zoster (HZ), intravenous injection or oral administration of Acyclovir (ACV) is common. Although this treatment has not provided satisfactory clinical results or prevention of post-herpitic-neuralgia (PHN). We developed a new localized injection therapy for HZ using the Bi-Digital O-Ring test (BDORT) and here report our initial clinical results.


We made a compound mixing ACV, xylocain, Vitamin B12 and high molecular weight substance of chondroitin sulfate. In 20 consecutive cases of HZ, this compound was injected subcutaneously in the section in which BDORT indicated positive resonance phenomenon of HZ virus (HZV).


Resonance phenomenon of HZV, Thromboxane B2 (TXB2) & Substance P disappeared immediately after injection in all cases.
Although the pain disappeared immediately after the injection in most cases, additional injection was needed in a few cases.
BDORT revealed that injected ACV and chondroitin sulfate remained in the section for 2 days and 4 days respectively.
No concurrence of PHN was observed in 20 cases.
Side-reaction of the therapy was minimal.

We realized, using BDORT, that a marked increase of TXB2 existed in the section with positive response of HZV and that ACV administered intravenously did not reach sufficiently into the section. In conclusion, our new, localized injection therapy could provide sufficient ACV to the section and effectively prevent PHN in comparison with conventional intravenous ACV injection therapy.

Cognizant Communication Corporation.


By Muneyoshi Oka

Share this with your friends